Workflow
药明康德涨近4% 今日将发三季报 公司TIDES业务发展势头不变
Zhi Tong Cai Jing·2025-10-24 06:58

Core Viewpoint - WuXi AppTec (603259) (02359) shares rose nearly 4%, currently up 3.76% at HKD 110.3, with a trading volume of HKD 518 million. The company plans to hold a board meeting on October 24 to consider and approve its third-quarter results for the nine months ending September 30, 2025. [1] Group 1 - The TIDES business continues to show strong growth momentum, with rapid capacity expansion and a rich pipeline reserve [1] - Early-stage research is showing further signs of recovery, which is expected to drive growth in early-stage business revenue, accounting for approximately one-third of the company's total revenue [1] - Refined operations are helping the company maintain resilient profitability amid macro uncertainties and global capacity expansion [1] Group 2 - JPMorgan continues to list WuXi AppTec as a preferred stock in China's CXO sector, highlighting the company as the largest contract research and manufacturing organization in China [1] - The firm is optimistic about the company's business fundamentals, noting that competition in the small molecule CRDMO sector remains relatively mild, while the growth momentum in WuXi's TIDES business remains strong [1]